Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
PYC Therapeutics (PYC AU)
Watchlist
7
Analysis
Health Care
•
Australia
Pyc Therapeutics Limited operates as a pharmaceutical company. The Company develops drugs and medicine for various types of diseases. Pyc Therapeutics serves customers in Australia.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
PYC Therapeutics
•
17 Aug 2024 04:20
•
Broker
PYC Therapeutics Limited - Flash Update
VP-001 received the most attention in the presentation and discussions, given recent positive updates showing improved visual function in the...
Canaccord Genuity
Follow
299 Views
Share
bullish
•
PYC Therapeutics
•
12 Aug 2024 21:22
•
Broker
PYC Therapeutics Limited - 2Q24: In Line, All Eyes on RP11 Data and ADPKD Trial Timing
PYC reported its 2Q24 result, in line with expectations around R&D spend and progress with clinical and preclinical assets.
Canaccord Genuity
Follow
120 Views
Share
bullish
•
PYC Therapeutics
•
12 Aug 2024 21:19
•
Broker
PYC Therapeutics Limited - Ticking the Boxes with Two Patients at Four Months with VP-001
PYC has announced follow-up data from the second patient in its Phase 1/2 study assessing VP-001 for Retinitis Pigmentosa 11 (RP11), a rare...
Canaccord Genuity
Follow
113 Views
Share
bullish
•
PYC Therapeutics
•
01 Jul 2024 07:59
•
Broker
PYC Therapeutics Limited - Making Sense of the PPMO-CPP Combination
Initiating on PYC Therapeutics with a BUY rating and risked price target of $0.22. PYC is a clinical stage biotechnology company in the gene...
Canaccord Genuity
Follow
214 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x